Smart anti-vascular nanoagent induces positive feedback loop for self-augmented tumor accumulation

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Efficient drug accumulation in tumors, especially those with low vascular density, remains a significant challenge for anti-vascular therapies.
• Existing therapeutic strategies often struggle to overcome poor drug penetration and retention in poorly vascularized tumor microenvironments.

Purpose of the Study:

• To develop a charge-reversible nanoparticle system (CRNP-GNA) that induces a positive feedback loop to enhance drug accumulation in tumors.
• To investigate the potential of CRNP-GNA to improve anti-vascular therapeutic efficacy by overcoming the limitations of low tumor vascular density.

Main Methods:

• Formulation of charge-reversible nanoparticles of gambogenic acid (CRNP-GNA).
• In vivo evaluation of CRNP-GNA in tumor models with low vascular density, assessing drug accumulation, vascular permeability, and retention.
• Comparison of CRNP-GNA with its charge-irreversible analogue.

Main Results:

• CRNP-GNA significantly boosted tumor drug accumulation (8.32 times) and vascular permeability and retention indexes (VPRI) (60 times) compared to its analogue.
• CRNP-GNA treatment led to a substantial decrease in tumor microvessel density (7%).
• CRNP-GNA demonstrated potent antitumor efficacy, achieving complete tumor regression in 5 out of 6 animal models through anti-angiogenesis, vascular disruption, and pro-apoptosis.

Conclusions:

• Charge-reversible nanoparticles can induce a positive feedback loop, enabling self-augmented drug accumulation even in tumors with poor vascularization.
• This novel nanosystem provides a promising strategy to address the critical challenge of balancing anti-vascular efficacy with effective drug delivery.
• CRNP-GNA represents a significant advancement in overcoming therapeutic resistance in challenging tumor microenvironments.